Essential Role of CCR6 in Directing Activated T Cells to the Skin during Contact HypersensitivityPARADIS, Timothy J; COLE, Susan H; NELSON, Robin T et al.Journal of investigative dermatology. 2008, Vol 128, Num 3, pp 628-633, issn 0022-202X, 6 p.Article

Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715CLUCAS, Alan T; SHAH, Ajit; YUANCHAO ZHANG et al.Clinical pharmacokinetics. 2007, Vol 46, Num 9, pp 757-766, issn 0312-5963, 10 p.Article

Potent small molecule CCR1 antagonistsKATH, John C; BRISSETTE, William H; MARTIN, William H et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 9, pp 2169-2173, issn 0960-894X, 5 p.Article

Piperazinyl CCR1 antagonists : optimization of human liver microsome stabilityBROWN, Matthew F; BAHNCK, Kevin B; GUZMAN-MARTINEZ, Aikomari et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 11, pp 3109-3112, issn 0960-894X, 4 p.Article

Novel CCR1 antagonists with improved metabolic stabilityBROWN, Matthew F; AVERY, Mike; LIRA, Paul D et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 9, pp 2175-2179, issn 0960-894X, 5 p.Article

The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu miceGLADUE, Ronald P; PARADIS, Timothy; BEDIAN, Vahe et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 7, pp 1009-1017, issn 0340-7004, 9 p.Article

CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infectionHOKENESS, Kirsten L; DEWEERD, Elizabeth S; MUNKS, Michael W et al.Journal of virology. 2007, Vol 81, Num 3, pp 1241-1250, issn 0022-538X, 10 p.Article

Genomic organization of the CC chemokine MIP-3α/CCL20/LARC/ EXODUS/SCYA20, showing gene structure, splice variants, and chromosome localizationNELSON, Robin T; BOYD, James; NEOTE, Kuldeep S et al.Genomics (San Diego, Calif.). 2001, Vol 73, Num 1, pp 28-37, issn 0888-7543Article

CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE^-/- miceAIELLO, Robert J; PERRY, Bret D; BOURASSA, Patricia-Ann et al.Atherosclerosis. 2010, Vol 208, Num 2, pp 370-375, issn 0021-9150, 6 p.Article

Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligandsMCCOLL, Shaun R; MAHALINGAM, Surendran; STAYKOVA, Maria et al.Laboratory investigation. 2004, Vol 84, Num 11, pp 1418-1429, issn 0023-6837, 12 p.Article

The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere templateKATH, John C; DIRICO, Amy P; GLADUE, Ronald P et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 9, pp 2163-2167, issn 0960-894X, 5 p.Article

The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNyPARADIS, Timothy J; FLOYD, Eugenia; BURKWIT, Jeff et al.Cancer immunology and immunotherapy. 2001, Vol 50, Num 3, pp 125-133, issn 0340-7004Article